Cary Street Partners Investment Advisory’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-90
Closed -$3.02K 1742
2023
Q3
$3.02K Hold
90
﹤0.01% 1597
2023
Q2
$3.38K Hold
90
﹤0.01% 1502
2023
Q1
$2.64K Hold
90
﹤0.01% 1459
2022
Q4
$2.37K Buy
+90
New +$2.14K ﹤0.01% 1484

Other funds holding VCEL

Cary Street Partners Investment Advisory's VCEL Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Vericel Corp (VCEL) in Q4 2023, closing a stake of 90 shares — an estimated $3.02K sold.

Cary Street Partners Investment Advisory first reported a position in VCEL in Q4 2022 and held it in 4 quarters. The position peaked at $3.38K in Q2 2023. 227 funds tracked by Wall St. Rank hold VCEL as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Vericel Corp position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 90 Vericel Corp shares in Q4 2023, an estimated $3.02K.
  • Cary Street Partners Investment Advisory first reported a position in Vericel Corp in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Vericel Corp position peaked at $3.38K in Q2 2023.
  • 227 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.